Ingredient & Evidence

Psyllium Husk and Glucomannan: How Two Viscous Fibres in FloraNew Work, and What Clinical Trials Actually Used

Two of the eight ingredients on FloraNew's label — Psyllium Husk Powder and Glucomannan Powder — are also two of the most heavily studied fibres in gastroenterology. Both have a real, published evidence base for regularity and bloating-adjacent outcomes. But "well studied" and "delivered at a study-matching dose" are two different claims, and the gap between them is exactly what this article works through: what the trials actually used, how these fibres work mechanically, and why FloraNew's own label format makes it impossible to say whether its blend comes close to those doses.

The mechanism: why "viscous" and "gel-forming" matter

Not all fibre behaves the same way in the gut, and the difference is not just "soluble versus insoluble." A widely cited 2017 review in the Journal of the Academy of Nutrition and Dietetics makes the case that viscosity specifically — a fibre's ability to thicken into a gel when mixed with water — is what drives certain benefits. High-viscosity, gel-forming fibres like psyllium reliably support healthy cholesterol and blood sugar responses, while nonviscous soluble fibres (inulin and wheat dextrin, for example) do not provide those same viscosity-dependent benefits. For laxation specifically, the review describes two separate physical mechanisms: insoluble fibre particles mechanically stimulate the gut lining, while gel-forming, water-holding fibres add bulk and softness by retaining water as they pass through largely intact. Psyllium and glucomannan both belong to this second, gel-forming category, which is why they show up again and again in constipation and regularity trials specifically, rather than in every "high fibre" study indiscriminately.

Psyllium husk: what the trials found

Psyllium husk (from Plantago ovata) is arguably the best-evidenced fibre for regularity in the literature, and it is a first-line recommendation in mainstream gastroenterology for that reason. A 2022 systematic review and meta-analysis published in the American Journal of Clinical Nutrition pooled results across multiple fiber-supplementation trials for chronic constipation. It found that 311 of 473 participants (66%) responded to fiber treatment, compared with 134 of 329 (41%) on control, and that fiber meaningfully increased both stool frequency and stool consistency scores. Critically, the review found the effect was dose- and duration-dependent: doses above roughly 10 grams per day, sustained for at least four weeks, were most strongly associated with a real response, and psyllium and pectin specifically were flagged among the best-performing fiber types in the pooled data. The same review also found flatulence was reliably higher in fiber groups than controls — a fair reminder that "more regular" and "more gas, especially at first" tend to arrive together.

A separate double-blind, placebo-controlled trial looked specifically at psyllium's effect on gut microbiota over seven days in both constipated and healthy volunteers, comparing psyllium against a maltodextrin placebo. It found psyllium shifted several bacterial genera associated with short-chain fatty acid production in constipated participants specifically, with smaller effects in healthy volunteers — evidence that psyllium's benefit may be more pronounced in people who are actually constipated to begin with, rather than a universal effect.

Glucomannan: what the trials found

Glucomannan, extracted from the konjac root (Amorphophallus konjac), is one of the most viscous dietary fibres known — it can absorb many times its weight in water. A controlled trial published in the Journal of the American College of Nutrition tested konjac glucomannan supplementation in constipated adults eating a low-fiber Chinese diet. Participants took 1.5 grams of glucomannan three times a day (4.5 grams total daily) for 21 days, following a 21-day placebo run-in phase. Weekly bowel movement frequency rose from an average of 4.1 to 5.3 — roughly a 30% increase — and the researchers also measured increases in beneficial fecal bacteria (including lactobacilli) and short-chain fatty acid production, alongside a lower fecal pH. A more recent double-blind randomized controlled trial, published in 2025 in the European Journal of Nutrition, tested konjac glucomannan specifically in athletes with functional constipation and again used comparable gram-level daily dosing to assess gastrointestinal symptoms and gut microbiota changes.

The throughline across both fibres' trial literature is consistent: benefits appear at gram-level daily intakes of a single, specific fibre, sustained for at least a few weeks, not at trace or sub-gram amounts buried inside a broader multi-ingredient blend.

Fibre	Representative trial dose	Trial duration	Main measured outcome
Psyllium husk (general fiber review)	>10 g/day (pooled analysis threshold)	≥4 weeks	66% responder rate vs 41% control; improved stool frequency & consistency
Psyllium husk (microbiota trial)	Not stated in abstract	7 days	Shifted short-chain-fatty-acid-producing bacterial genera in constipated adults
Glucomannan (konjac, low-fiber diet trial)	4.5 g/day (1.5 g, 3x daily)	21 days	Weekly bowel movements rose ~30% (4.1 → 5.3)
Glucomannan (2025 athlete RCT)	Gram-level daily dose	Double-blind RCT	GI symptoms & gut microbiota assessed

Now the honest part: what FloraNew's own label does and doesn't let you compare

FloraNew's sales page states the product is a 695mg Proprietary Cleanse Blend containing eight ingredients: Oat Bran Powder, Flax Seed Powder, Psyllium Husk Powder, Apple Pectin Powder, Glucomannan Powder, Black Walnut Hull, Plum Fruit, and Lactobacillus acidophilus (1.5 Billion CFUs). Psyllium husk and glucomannan are both on that list — but neither has its own individually printed amount. The entire blend, all eight ingredients combined, totals 695 milligrams, which is well under one gram.

Compare that to the trial doses above: the glucomannan trial alone used 4.5 grams of a single ingredient per day, and the pooled fiber-constipation review flagged >10 grams per day as the threshold most associated with a real response. Even in the most generous possible reading — if psyllium and glucomannan somehow made up the entire 695mg blend between just the two of them, with none of the other six ingredients present at all — that would still fall well short of the gram-level amounts used in these trials. In reality, FloraNew's label lists eight ingredients sharing that 695mg total, which means whatever psyllium and glucomannan individually contribute is necessarily a fraction of an already sub-gram figure.

We want to be precise about what this does and does not mean. It does not mean FloraNew's psyllium husk or glucomannan "doesn't work" — we have no printed amount to evaluate, so we cannot make either claim. It does mean that, based on the label as currently printed, no one can honestly claim FloraNew delivers a clinical-trial dose of either ingredient, because the amounts needed to make that comparison simply are not published. If matching a specific published trial dose is important to you, the accurate next step is asking the seller directly for the individual per-ingredient breakdown, since the current page does not provide one.

What the printed ingredient order can, and can't, hint at

FloraNew's ingredient cards list Oat Bran Powder first and Psyllium Husk Powder third, with Glucomannan Powder fifth. If that order does reflect descending weight — which the page does not explicitly confirm, as we cover in our companion article on the proprietary blend format — it would suggest oat bran and flax seed make up a larger share of the 695mg than psyllium husk, apple pectin or glucomannan do, since those two are listed ahead of the others. That is a plausible reading, not a confirmed one, and it does not change the underlying math: even if psyllium and glucomannan were the largest two components of the blend, the entire 695mg is still far short of a single gram-level trial dose for either fibre on its own.

It is also worth being fair to the other direction: a lower amount inside a blend does not automatically mean an ingredient does nothing. Some compounds are active at small quantities. The issue here specifically is that psyllium and glucomannan are not that kind of ingredient — the clinical literature above evaluated them at gram-level doses, not milligram-level ones, so a sub-gram share of a 695mg blend sits below the range that literature actually tested, regardless of how "active" the ingredient can be in principle.

Who this evidence is, and isn't, directly relevant to

The trials referenced above generally enrolled adults with functional constipation or chronic idiopathic constipation, evaluated over days to weeks, and measured objective outcomes like weekly bowel movement counts or validated stool-consistency scales. That is a reasonably close match to the kind of "occasional bloating" and "regularity" claims FloraNew's marketing makes. It is a less direct match if your main concern is a diagnosed digestive condition such as IBS, a structural bowel issue, or an unexplained change in bowel habit — those situations call for a conversation with a doctor rather than a fibre capsule, regardless of dose.

Practical takeaways

• Psyllium and glucomannan are genuinely well-studied fibres with real, gram-level trial evidence for regularity and stool consistency.
• Both work through the same core mechanism: forming a viscous gel in the presence of water, which adds bulk, retains water, and softens stool.
• FloraNew's label states a combined 695mg for its whole eight-ingredient blend, not an individual amount for either fibre.
• Trial doses of these fibres run into multiple grams per day, per ingredient — several times the weight of FloraNew's entire blend combined.
• Take any viscous fibre with a full glass of water. Every trial referenced here delivered its fibre with adequate fluid; without it, gel-forming fibres can worsen bloating rather than relieve it.

Frequently asked questions